87 related articles for article (PubMed ID: 15535209)
1. [Molecular mechanism in carcinogenesis of the uterine cervix].
Nakagawa S; Taketani Y
Nihon Rinsho; 2004 Oct; 62 Suppl 10():73-7. PubMed ID: 15535209
[No Abstract] [Full Text] [Related]
2. Papillomavirus and p53.
zur Hausen H
Nature; 1998 May; 393(6682):217. PubMed ID: 9607756
[No Abstract] [Full Text] [Related]
3. [Molecular carcinogenesis of the uterine cervix].
Enomoto T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():61-5. PubMed ID: 15535206
[No Abstract] [Full Text] [Related]
4. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
5. [Genetic abnormality in cervical cancer].
Umayahara K
Nihon Rinsho; 2004 Oct; 62 Suppl 10():66-8. PubMed ID: 15535207
[No Abstract] [Full Text] [Related]
6. p53 polymorphism and risk of cervical cancer.
Josefsson AM; Magnusson PK; Ylitalo N; Quarforth-Tubbin P; Pontén J; Adami HO; Gyllensten UB
Nature; 1998 Dec; 396(6711):531; author reply 532. PubMed ID: 9859988
[No Abstract] [Full Text] [Related]
7. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of HPV E6 proteins in cellular transformation.
Huibregtse JM; Beaudenon SL
Semin Cancer Biol; 1996 Dec; 7(6):317-26. PubMed ID: 9284524
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of human papillomavirus-induced oncogenesis.
Münger K; Baldwin A; Edwards KM; Hayakawa H; Nguyen CL; Owens M; Grace M; Huh K
J Virol; 2004 Nov; 78(21):11451-60. PubMed ID: 15479788
[No Abstract] [Full Text] [Related]
10. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
11. p53 polymorphism and risk of cervical cancer.
Hildesheim A; Schiffman M; Brinton LA; Fraumeni JF; Herrero R; Bratti MC; Schwartz P; Mortel R; Barnes W; Greenberg M; McGowan L; Scott DR; Martin M; Herrera JE; Carrington M
Nature; 1998 Dec; 396(6711):531-2. PubMed ID: 9859989
[No Abstract] [Full Text] [Related]
12. Correspondence re: Ferguson AM, Svoboda-Newman SM, Frank TS: Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 1:11-18, 1998.
Tenti P; Zappatore R; Carnevali L
Mod Pathol; 1999 Dec; 12(12):1192-3. PubMed ID: 10619275
[No Abstract] [Full Text] [Related]
13. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
15. The role of TP53 in Cervical carcinogenesis.
Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I
Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117
[TBL] [Abstract][Full Text] [Related]
16. [The role of human papillomavirus in carcinogenesis of cervical cancer and vaccination for HPV].
Kariya M; Fujii S
Uirusu; 2002 Dec; 52(2):287-93. PubMed ID: 12685321
[No Abstract] [Full Text] [Related]
17. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
18. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
19. Centrosome-mediated chromosomal instability and steroid hormones as co factors in human papillomavirus-associated cervical carcinogenesis: small viruses help to answer big questions.
Duensing A; Duensing S
Adv Exp Med Biol; 2008; 617():109-17. PubMed ID: 18497035
[No Abstract] [Full Text] [Related]
20. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]